
Reviving a Forgotten Antibiotic: A Potential Superbug Killer
An antibiotic called streptothricin, developed 80 years ago but abandoned due to toxicity concerns, is being revisited by researchers at Harvard University. Now known as nourseothricin, one of its components, streptothricin F (S-F), has shown promise in killing drug-resistant gram-negative bacteria without toxicity. The antibiotic works by interfering with the protein-making machinery of the bacteria. Researchers hope to enhance streptothricins to develop a new class of antibiotics to combat highly resistant bacteria.
